bevacizumab - Robuta Search

https://pubmed.ncbi.nlm.nih.gov/20958992/ "Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin... Osservatorio Nazionale sulla Sperimentazione Clinica dei Medicinali (OsSC) Agenzia Italiana del Farmaco (AIFA) Numero EudraCT 2007-004946-34. poker association weekly alternating https://scholars.uky.edu/es/publications/a-phase-i-pharmacodynamic-trial-of-sequential-sunitinib-with-beva/fingerprints/ A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal... https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT01295944&r=1 Carboplatin and Bevacizumab for Recurrent Ependymoma - NCI Carboplatin and Bevacizumab for Recurrent Ependymoma carboplatin bevacizumab recurrent ependymoma nci https://experts.mcmaster.ca/scholarly-works/1757578 Bevacizumab in advanced lung cancer: in search of... Learn about the scholarly work entitled Bevacizumab in advanced lung cancer: in search of... advanced lung cancer bevacizumab search https://ub01.uni-tuebingen.de/xmlui/handle/10900/62473 Effects of a human VEGF antibody (Bevacizumab) on deprivation myopia and choroidal thickness in the... https://adisinsight.springer.com/drugsafety/803065393?error=cookies_not_supported&code=64f94aa7-2380-47d4-b059-e229a8b7229a Bevacizumab - AdisInsight Two patients with metastatic colorectal cancer developed clubbing and either hypertrophic osteoarthropathy or a lung diffusion disorder after receiving bevacizumab adisinsight https://ub01.uni-tuebingen.de/xmlui/handle/10900/106423 Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label,... https://www.nice.org.uk/guidance/ta178/chapter/4-Evidence-and-interpretation 4 Evidence and interpretation | Bevacizumab (first-line), sorafenib (first- and second-line),... Evidence-based recommendations on bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for treating advanced or metastatic... first line evidence interpretation bevacizumab sorafenib https://ec2-3-220-198-172.compute-1.amazonaws.com/ovario-phase-ii-trial-of-combination-niraparib-plus-bevacizumab-maintenance-therapy-in-advanced-ovarian-cancer-following-first-line-platinum-based-chemotherapy-with-bevacizumab/ OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced... Nov 16, 2023 - FCS hematologist and medical oncologist Gail Wright, MD, FACP, FCCP co-authored a recent phase II study assessing the safety and efficacy of niraparib +... https://scholars.uky.edu/en/publications/phase-i-and-clinical-pharmacology-study-of-bevacizumab-sorafenib-/ Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in... https://scholars.duke.edu/publication/768334 Scholars@Duke publication: Bevacizumab-induced reversible posterior leukoencephalopathy syndrome... scholars duke publication bevacizumab induced https://pmc.ncbi.nlm.nih.gov/articles/PMC12497873/ Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate... Transarterial chemoembolization (TACE) is the standard treatment for intermediate-stage hepatocellular carcinoma (HCC), yet its efficacy as a standalone... in patients chemoembolization plus atezolizumab bevacizumab https://cris.tau.ac.il/en/publications/first-line-bevacizumab-plus-taxane-based-chemotherapy-for-locally/ First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast... https://pubmed.ncbi.nlm.nih.gov/21386839/ FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer FOLFOX6+bevacizumab does not increase postsurgical complications, yields high rates of resectability and pCR. Early changes in PET-CT seem to be predictive of... https://scholars.lib.ntu.edu.tw/entities/project/212a425d-9766-4afe-8ed6-7f213410c492 Underlying Mechanisms of Bevacizumab on the Inhibition of Corneal Neovascularization on the underlying mechanisms bevacizumab inhibition https://pure.psu.edu/en/publications/bevacizumab-when-added-to-paclitaxelcarboplatin-prolongs-survival/ Bevacizumab, when added to paclitaxel/carboplatin, prolongs survival in previously untreated... bevacizumab added paclitaxel https://adisinsight.springer.com/drugsafety/801111114?error=cookies_not_supported&code=606166ab-7a46-4417-8623-4e2657d5d6cc Bevacizumab - AdisInsight A 61-year-old woman, who had a history of ileotransversostomy and chemotherapy for colorectal cancer, experienced ischaemic anastomotic intestinal perforation bevacizumab adisinsight https://www.news-medical.net/health/Avastin-(Bevacizumab)-Indications.aspx Avastin (Bevacizumab) Indications Jul 14, 2023 - Bevacizumab (brand name Avastin) is an anti-cancer therapy that belongs to a group of drugs called monoclonal antibodies. A monoclonal antibody is a drug... avastin bevacizumab indications https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=52370&ver=119&= Article - Billing and Coding: Bevacizumab and biosimilars (A52370) Use this page to view details for the Local Coverage Article for Billing and Coding: Bevacizumab and biosimilars. billing and coding article bevacizumab biosimilars https://pubmed.ncbi.nlm.nih.gov/19707343/ First line targeted therapies in breast cancer: focus on bevacizumab The heterogeneity of metastatic breast cancer mandates the need to select therapies taking into account tumor and patient characteristics. Chemotherapy is... first line targeted therapies breast cancer focus on bevacizumab https://open.library.emory.edu/concern/publications/81cefaf1-e782-4909-971f-97ac30875026?locale=en Intrastromal Delivery of Bevacizumab Using Microneedles to Treat Corneal Neovascularization |... Intrastromal Delivery of Bevacizumab Using Microneedles to Treat Corneal Neovascularization delivery bevacizumab using microneedles treat https://www.innovative-ctu.ucl.ac.uk/news/news-stories/2023/october/having-more-frequent-chemotherapy-and-bevacizumab-treats-advanced-ovarian-cancer-more-effectively/ Having more frequent chemotherapy and bevacizumab treats advanced ovarian cancer more effectively |... ovarian cancer frequent chemotherapy https://scholars.duke.edu/publication/1434802 Scholars@Duke publication: The role of large volume re-irradiation with Bevacizumab in... https://adisinsight.springer.com/trials/700199801?error=cookies_not_supported&code=4a8db633-ede1-447c-aa30-59cf2e62bbfc A Randomized, Double-blinded, Placebo-controlled, Multicenter Phase III Study Comparing Bevacizumab... This study is comparing the efficacy and tolerability of carboplatin + paclitaxel with or without bevacizumab for the first-line treatment of Chinese patients https://adisinsight.springer.com/trials/700374315?error=cookies_not_supported&code=9727f7b4-0f8e-42a0-ae7c-657be34b2af5 Efficacy and Safety of Socazolimab Combined With Chemotherapy With or Without Bevacizumab as... The goal of this clinical trial is to evaluate the efficacy and safety of Socazolimab combined with chemotherapy with or without bevacizumab as first-Line efficacy and safety https://pubmed.ncbi.nlm.nih.gov/40861099/ Radiomics-based prediction of HCC response to atezolizumab/bevacizumab Advanced hepatocellular carcinoma (HCC) treatment has evolved with the introduction of atezolizumab/bevacizumab, showing improved outcomes over sorafenib.... radiomics based prediction hcc response https://www.innovative-ctu.ucl.ac.uk/news/news-stories/2015/june/adding-bevacizumab-to-chemotherapy-helps-women-with-high-risk-ovarian-cancer-to-live-longer/ Adding bevacizumab to chemotherapy helps women with high-risk ovarian cancer to live longer | UCL... https://pubmed.ncbi.nlm.nih.gov/37682504/ Impact of Cardiovascular Comorbidities on the Effectiveness and Safety of Bevacizumab in Older... In clinical practice, cardiovascular comorbidities before administering bevacizumab to older patients with metastatic colorectal cancer impacted the... on the https://adisinsight.springer.com/drugsafety/803925684?error=cookies_not_supported&code=b89daec0-9d46-4066-a12e-a7b71bd416af Atezolizumab/Bevacizumab - AdisInsight A man with hepatocellular carcinoma developed acquired haemophilia A following treatment with atezolizumab and bevacizumab. atezolizumab bevacizumab adisinsight https://adisinsight.springer.com/drugsafety/803924208?error=cookies_not_supported&code=6ea3b070-c55d-4e21-bfac-44722db25468 Bevacizumab - AdisInsight A 56-year-old woman with fallopian tube carcinoma developed an aortoenteric fistula after receiving bevacizumab, representing a serious adverse drug reaction. bevacizumab adisinsight https://adisinsight.springer.com/trials/700356584?error=cookies_not_supported&code=cdb06bd2-4d9b-4064-933d-501c2ae2fa30 Fecal Microbiota Transplant (FMT) Combined With Atezolizumab Plus Bevacizumab in Patients With... This single-center, pilot study (phase IIa) will evaluate the safety, feasibility, and efficacy of FMT from patients with HCC who responded to PD-(L)1-based fecal microbiota transplant fmt combined https://pubmed.ncbi.nlm.nih.gov/19406901/?dopt=Abstract Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in... The BEAT study shows that the efficacy and safety profile of bevacizumab in routine clinical practice is consistent with results observed in prospective... safety and efficacy https://adisinsight.springer.com/drugsafety/803515337?error=cookies_not_supported&code=e7247838-9e97-4faa-8a39-df06727b6eba Bevacizumab/dexamethasone/oxaliplatin - AdisInsight A 73-year-old man developed drug-induced immune thrombocytopenia (DITP) during treatment with dexamethasone as an antiemetic prophylaxis and bevacizumab and bevacizumab dexamethasone oxaliplatin adisinsight https://pubmed.ncbi.nlm.nih.gov/28128986/ Comparison of Intravitreal Bevacizumab, Intravitreal Ranibizumab and Laser Photocoagulation for... IVB, IVR and LP are options that can successfully treat ROP. Myopia was observed to be the main refractive error in all treatment groups. Vascularization of... laser photocoagulation comparison bevacizumab ranibizumab https://adisinsight.springer.com/drugsafety/803313107?error=cookies_not_supported&code=c6b28395-8486-4792-835a-9edc7aa311c2 Bevacizumab - AdisInsight A 65-year-old woman developed fatal intrapulmonary haemorrhage and arteriobronchial fistula during treatment with bevacizumab [dosage and route not stated].The bevacizumab adisinsight https://adisinsight.springer.com/drugsafety/803929747?error=cookies_not_supported&code=98ba1823-9d0d-4972-8f3f-f55ad80f2fb1 Bevacizumab - AdisInsight A 65-year-old man with chronic hepatitis B not receiving medication and incidentally detected infiltrative hepatocellular carcinoma received bevacizumab adisinsight https://scholars.duke.edu/publication/1431799 Scholars@Duke publication: Rindopepimut with Bevacizumab for Patients with Relapsed... for patients scholars duke publication bevacizumab https://adisinsight.springer.com/trials/700359291?error=cookies_not_supported&code=c7c93777-45f0-4718-b934-cb01130ee7c0 A Phase Ib/II Trial of Capeox Regimen Combined With Sintilimab and Bevacizumab in First-line... The median survival time of first-line chemotherapy for advanced gastric cancer is about one year, and the treatment is still facing the bottleneck. This is a https://medicine.yale.edu/dfri/trial/ea5182-randomized-phase-iii-study-of-combination-osimertinib-azd9291-and-bevacizumab-versus-osime/ Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib... This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that phase iii randomized study https://adisinsight.springer.com/drugsafety/803927272?error=cookies_not_supported&code=fcf3b2b6-2f57-455b-b4af-18d4be944722 Bevacizumab/Irinotecan/Temozolomide - AdisInsight Sixty-six patients aged under 25 years with relapsed or refractory neuroblastoma [sex not stated] received combination bevacizumab, irinotecan and temozolomide bevacizumab irinotecan temozolomide adisinsight https://adisinsight.springer.com/trials/700392585?error=cookies_not_supported&code=071231c0-bb28-41ae-9808-30fc9760a6ee Phase II, Randomized Trial of Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for... Arm1- bevacizumab (Onbevzi) at a dose of 15 mg/kg administered as a 30-minute intravenous infusion on Day 1 of each 21-day cycle, followed by intravenous https://pubmed.ncbi.nlm.nih.gov/36340047/ The short-term effects of intravitreal bevacizumab injection on intraocular pressure, cornea,... IVB (2.5 mg/0.1 mL) injection causes transient increases in IOP and transient decreases in ACD and ICA at the first hour after injection. Related to elevation... short term https://www.nice.org.uk/guidance/ta178/chapter/5-Implementation 5 Implementation | Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib... Evidence-based recommendations on bevacizumab (Avastin), sorafenib (Nexavar), sunitinib (Sutent) and temsirolimus (Torisel) for treating advanced or metastatic... first line implementation bevacizumab sorafenib second https://scholarworks.indianapolis.iu.edu/items/3f9bcb78-b8db-48a1-9e4a-064193b0f19e Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional... Purpose: Low-dose and very low-dose intravitreal bevacizumab (IVB) have been reported to be successful in short-term treatment of type 1 retinopathy of... retinopathy of prematurity low dose bevacizumab https://ub01.uni-tuebingen.de/xmlui/handle/10900/38934?show=full Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on... comparative toxicity proliferation testing aflibercept https://pubmed.ncbi.nlm.nih.gov/25088940/?dopt=Abstract FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with... https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-either-ixabepilone-or-paclitaxel-chemotherapy-in-combination-with-bevacizumab-for-breast-cancer-that-has-come-back-locally-or-has-spread A trial looking at either ixabepilone or paclitaxel with bevacizumab for breast cancer that has... This trial looked at either ixabepilone with bevacizumab (Avastin) or paclitaxel with bevacizumab for breast cancer that has come back after treatment. https://pubmed.ncbi.nlm.nih.gov/36402005/ NSCLC with uncommon EGFR mutations treated with atezolizumab plus bevacizumab and chemotherapy In this retrospective analysis, ABCP achieves an encouraging outcome for patients with uncommon EGFR mutations and is a valuable option in the early treatment... nsclc uncommon egfr mutations https://pure.psu.edu/en/publications/effect-of-lyophilization-on-the-in-vitro-biological-activity-of-b/fingerprints/ Effect of lyophilization on the in vitro biological activity of bevacizumab - Fingerprint - Penn... on the in vitro https://www.avastin.com/patient/mcrc.html How Avastin® (bevacizumab) works for the treatment of metastatic colorectal cancer (mCRC) Learn about Avastin® (bevacizumab) solution for IV infusion, including benefits, risks, possible side effects, patient support, and options for financial help.... metastatic colorectal cancer for the https://adisinsight.springer.com/drugsafety/803164955?error=cookies_not_supported&code=581a5b04-0097-4b03-958d-966f9ddc1182 Bevacizumab - AdisInsight An elderly man developed proctitis following treatment with bevacizumab for locally advanced rectal cancer and non-metastatic prostate cancer [patient age at bevacizumab adisinsight https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1401000/full Frontiers | The efficacy of stereotactic radiotherapy followed by bevacizumab and temozolomide in... Glioblastoma (GBM) is the most common and aggressive malignant brain tumor among adults. Despite advancements in multimodality therapy for GBM, the overall p... stereotactic radiotherapy https://pubmed.ncbi.nlm.nih.gov/17167137/?dopt=Abstract Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer The addition of bevacizumab to paclitaxel plus carboplatin in the treatment of selected patients with non-small-cell lung cancer has a significant survival... https://adisinsight.springer.com/trials/700375951?error=cookies_not_supported&code=eed89f19-2caf-4a8f-baa5-e7312eb019bb A real-life study to determine therapeutic effect and safety of atezolizumab and Bevacizumab of... To determine therapeutic effect and safety of atezolizumab and Bevacizumab of acute variceal bleeding during treatment in Korea. a real life https://pubmed.ncbi.nlm.nih.gov/31558474/ Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with... Bevacizumab led to a decrease in permeability and concomitant delivery of temozolomide. However, in subregions of the tumor where permeability was low,... https://scholars.duke.edu/publication/1355293 Scholars@Duke publication: Bevacizumab and Brain Tumors scholars duke publication bevacizumab brain https://pubmed.ncbi.nlm.nih.gov/26951379/ AVAREG: a phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients... Single-agent bevacizumab may have a role in patients with recurrent glioblastoma. https://pubmed.ncbi.nlm.nih.gov/21976315/ Bevacizumab treatment for advanced breast cancer Significant advances in the treatment of patients with breast cancer have been made in the past 10 years. The current systemic treatment of breast cancer is... treatment for bevacizumab advanced breast cancer https://adisinsight.springer.com/drugsafety/803927724?error=cookies_not_supported&code=d2b9f7ac-3976-4223-91d7-99bd459f127a Bevacizumab - AdisInsight Thirty-three patients with newly diagnosed glioblastoma [age and sex not stated] received preoperative neoadjuvant bevacizumab 10 mg/kg [route and treatment bevacizumab adisinsight https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-chemotherapy-bevacizumab-mucinous-ovarian-cancer-meoc A trial looking at chemotherapy with or without bevacizumab for mucinous ovarian cancer (mEOC) This trial is comparing 2 different chemotherapy combinations with or without bevacizumab for a rare type of ovarian cancer called mucinous epithelial. https://adisinsight.springer.com/drugsafety/803106593?error=cookies_not_supported&code=8641fff8-cab1-4408-837c-66cfa2d250a8 Bevacizumab/corticosteroids - AdisInsight A 55-year-old woman who received bevacizumab [Avastin] and unspecified corticosteroid therapy developed dural anastomotic dehiscence.The woman, who had been bevacizumab corticosteroids adisinsight https://researchconnect.buffalo.edu/en/publications/phase-ii-trial-of-bevacizumab-thalidomide-docetaxel-and-prednison/ Phase II trial of bevacizumab, thalidomide, docetaxel, and prednisone in patients with metastatic... https://scholars.duke.edu/publication/874870 Scholars@Duke publication: PHASE II STUDY OF BEVACIZUMAB AND ERLOTINIB IN PATIENTS WITH RECURRENT... https://www.cms.gov/medicare/coverage/ide/approved-ide-studies-items/g150275-nct02743078 Phase II Trial Of Optune Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma | CMS phase ii https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06974&r=1 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and... Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined with Immunotherapy (Pembrolizumab) for pMMR,... the addition https://www.eyenews.uk.com/reviews/journal-reviews/post/does-intravitreal-bevacizumab-help-in-diabetic-retinopathy-related-vitreous-haemorrhage Does intravitreal bevacizumab help in diabetic retinopathy related vitreous haemorrhage? | Eye News diabetic retinopathy https://adisinsight.springer.com/trials/700352155?error=cookies_not_supported&code=8d8e8a5c-de69-4eea-8dc2-ac493120b16f A retrospective, multicenter study of efficacy and safety of atezolizumab plus bevacizumab in... To investigate whether neutrophil-to-lymphocyte ratio (NLR) can predict outcomes in patients with unresectable hepatocellular carcinoma (HCC) treated with efficacy and safety https://adisinsight.springer.com/drugsafety/801089459?error=cookies_not_supported&code=f8baa9a6-f2c0-42fd-81d4-1287502fed44 Bevacizumab - AdisInsight A 68-year-old man with metastatic renal cancer developed a vitreous haemorrhage shortly after initiating bevacizumab therapy.The man, who had a 5-year history bevacizumab adisinsight https://dukespace.lib.duke.edu/items/57c39c47-2904-4b4e-a78b-cb393f7eead4 A phase I study of ABT-510 plus bevacizumab in advanced solid tumors. Targeting multiple regulators of tumor angiogenesis have the potential to improve treatment efficacy. Bevacizumab is a monoclonal antibody directed against... phase i study https://adisinsight.springer.com/drugsafety/803864270?error=cookies_not_supported&code=6ed2b457-2974-40a5-b124-21c076d2eda8 Atezolizumab/bevacizumab/lenvatinib - AdisInsight In a retrospective study, involving 92 patients notified at tertiary medical center in Taiwan from May 2018 to March 2022, two patients [ages and sexes not atezolizumab bevacizumab lenvatinib adisinsight https://boris-portal.unibe.ch/entities/publication/9cfcf6f4-e5f0-4d73-aaf4-7101543353b1 Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase... An urgent need for new treatment modalities is emerging in elderly patients with acute myeloid leukemia (AML). We hypothesized that targeting VEGF might... https://pubmed.ncbi.nlm.nih.gov/32352320/ IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular... Hepatocellular carcinoma recurs in 70-80% of cases following potentially curative resection or ablation and the immune component of the liver microenvironment... https://adisinsight.springer.com/drugsafety/803923771?error=cookies_not_supported&code=1decb4b0-5868-4fb2-bbd0-39d7d3fcb9b1 Atezolizumab/Bevacizumab - AdisInsight A 68-year-old man with liver cancer developed acute intraoperative hyperkalaemia during surgical resection following neoadjuvant chemotherapy with atezolizumab atezolizumab bevacizumab adisinsight https://adisinsight.springer.com/drugsafety/803925329?error=cookies_not_supported&code=63ad02fd-58de-4f1a-883f-cb137d0820c2 Atezolizumab/Bevacizumab - AdisInsight A patient with hepatocellular carcinoma developed Fourniers gangrene during treatment with atezolizumab and bevacizumab. atezolizumab bevacizumab adisinsight https://adisinsight.springer.com/drugsafety/803925335?error=cookies_not_supported&code=d9fc87be-3aa9-497d-a71a-147f6f702ccd Bevacizumab - AdisInsight Patients with neovascular age-related macular degeneration (nAMD) experienced lack of efficacy during treatment with bevacizumab for nAMD, as evidenced by bevacizumab adisinsight https://pubmed.ncbi.nlm.nih.gov/36344654/ A randomized phase II trial of bevacizumab vs. bevacizumab and erlotinib as first-line... Combinatorial consolidation therapy with AE was associated with an improved progression-free survival in patients with Mullerian tumors. https://adisinsight.springer.com/drugsafety/803929906?error=cookies_not_supported&code=c81e2538-7832-4df0-bd24-9c881d71185d Atezolizumab/Bevacizumab - AdisInsight A 74-year-old man with recurrent hepatocellular carcinoma experienced rapid tumour progression due to lack of efficacy of atezolizumab and bevacizumab. The man atezolizumab bevacizumab adisinsight https://scholars.lib.ntu.edu.tw/entities/project/545fa191-2978-43b7-a2aa-ff2d40de48c1 The Role of CXCR4 Signaling in Prevention of Bevacizumab-Enhanced Glioma Invasion---From Molecular... https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa27acbd-d117-4350-aeee-17bc2e2c0ca4 DailyMed - ZIRABEV- bevacizumab-bvzr injection, solution dailymed bevacizumab injection solution https://pubmed.ncbi.nlm.nih.gov/31597662/ Randomized Phase 0/I Trial of the Mitochondrial Inhibitor ME-344 or Placebo Added to Bevacizumab in... ME-344 has significant biological antitumor activity in HER2-negative breast cancer, particularly after induction of vascular normalization and tissue... https://adisinsight.springer.com/drugsafety/803592552?error=cookies_not_supported&code=5e4a75ad-1049-4337-aa8d-c6bbfe5c5909 Bevacizumab - AdisInsight A retrospective study of 101 patients from the database at Memorial Sloan Kettering Cancer Center, who were treated with bevacizumab between January 2004 and bevacizumab adisinsight https://portal.fis.tum.de/en/publications/homologous-recombination-repair-gene-mutations-to-predict-olapari/ Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the... https://pmc.ncbi.nlm.nih.gov/articles/PMC12400637/ Optimizing bevacizumab dosing in first-line ovarian cancer treatment: the PGOG-ov1 trial - PMC The management of advanced ovarian cancer has significantly developed with the integration of bevacizumab into standard therapeutic regimens. While the... https://pubmed.ncbi.nlm.nih.gov/28756902/ Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a... National Cancer Institute. https://discovery.fiu.edu/display/pub304321 A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent... https://adisinsight.springer.com/drugsafety/803929841?error=cookies_not_supported&code=45582c29-3523-4f39-be1c-bf50d90f8e36 Bevacizumab/Ociperlimab/Tislelizumab - AdisInsight A patient with advanced hepatocellular carcinoma [age and sex not stated] experienced infusion-related reactions while receiving first-line treatment with bevacizumab adisinsight https://pubmed.ncbi.nlm.nih.gov/21654521/ A phase 2 trial of bevacizumab and high-dose interferon alpha 2B in metastatic melanoma Bevacizumab is a humanized recombinant monoclonal antibody that neutralizes vascular endothelial growth factor, an agent with proangiogenic effects in... https://adisinsight.springer.com/trials/700060526?error=cookies_not_supported&code=e0f7efd0-d6ee-4a0a-98e3-777f239d85ca A Randomized Phase II Trial of Bevacizumab (Avastin) and Temsirolimus (Torisel) in Combination With... This trial is investigating how well vinorelbine tartrate and cyclophosphamide work in combination with bevacizumab or temsirolimus in treating patients with https://adisinsight.springer.com/trials/700392535?error=cookies_not_supported&code=817753ab-ca80-4876-8f08-3b41cf4bcb1f Efficacy and Safety of Low-Dose Bevacizumab and Atezolizumab Combined With Transarterial... This is a prospective, single-arm, phase II clinical study designed to evaluate the efficacy and safety of low-dose bevacizumab plus atezolizumab combined with efficacy and safety low dose https://adisinsight.springer.com/trials/700050766?error=cookies_not_supported&code=27632c52-1c2d-4353-9338-1fde72138cca A Single-Arm, Phase 2 Trial of Pemetrexed, Cisplatin,and Bevacizumab as Induction, Followed by... This trial will investigate the efficacy of pemetrexed [Almita; Eli Lilly], cisplatin and bevacizumab as first-line treatment in patients with non-small cell https://pure.psu.edu/en/publications/bevacizumab-extends-survival-for-patients-with-nonsquamous-non-sm/ Bevacizumab extends survival for patients with nonsquamous non-small-cell lung cancer - Penn State small cell lung cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC12657762/ Lenvatinib vs. sorafenib as second-line treatment post atezolizumab plus bevacizumab for... Atezolizumab plus bevacizumab (A+B) is a standard first-line systemic therapy for unresectable hepatocellular carcinoma (HCC). However, optimal sequencing... second line https://adisinsight.springer.com/drugsafety/803924868?error=cookies_not_supported&code=4e7d9378-00b2-4d49-9b7f-c54c0c8a24df Bevacizumab - AdisInsight Seventy patients with gastrointestinal malignancies were treated with bevacizumab, either alone or in combination with radiotherapy, to assess the risk of bevacizumab adisinsight https://pubmed.ncbi.nlm.nih.gov/22411674/ Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis Use of intravitreous bevacizumab to treat macular edema in West Nile virus chorioretinitis https://pubmed.ncbi.nlm.nih.gov/24307987/ Effectiveness and safety of intensive triplet chemotherapy plus bevacizumab, FIr-B/FOx, in... Four-drug regimens, such as FIr-B/FOx schedule, can improve efficacy of first-line treatment of metastatic colorectal cancer (MCRC) patients. The present study... https://scholars.duke.edu/publication/760963 Scholars@Duke publication: Safety of bevacizumab in patients with metastatic breast cancer. https://health.economictimes.indiatimes.com/tag/bevacizumab Bevacizumab - Latest bevacizumab , Information & Updates - Health -ET HealthWorld ETHealthworld.com brings latest bevacizumab news, views and updates from all top sources for the Indian Health industry. latest information bevacizumab updates health et https://adisinsight.springer.com/drugsafety/803424850?error=cookies_not_supported&code=bd0fa63b-f56c-41d9-b0f1-24925c57fc2d Bevacizumab - AdisInsight A 56-year-old woman developed thrombotic microangiopathy during treatment with bevacizumab for invasive metastatic squamous cell carcinoma of cervix.The woman bevacizumab adisinsight https://adisinsight.springer.com/drugsafety/803710765?error=cookies_not_supported&code=0c1f82b0-a75b-41b2-bb23-0bffa736ef2a Atezolizumab/bevacizumab/ramucirumab - AdisInsight In a retrospective study, conducted between October 2020 to November 2021, involving 77 patients, a patient [age and sex not stated] was described, who atezolizumab bevacizumab ramucirumab adisinsight https://www.innovative-ctu.ucl.ac.uk/news/news-stories/2014/june/bevacizumab-may-improve-survival-in-ovarian-cancer/ Bevacizumab may improve survival in ovarian cancer | UCL Innovative Clinical Trials Unit ovarian cancer